Expression of VEGF-C and VEGF-CR in Oral Cancers and Premalignant Lesions

The Role of Vascular Endothelial Growth Factor-C (VEGF-C) and Its Receptors Induced Lymphangiogenesis on the Carcinogenesis of Oral Cancers and Premalignant Lesions

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00173316

Enrollment

Registered

2005-09-15

Start date

2004-08-31

Completion date

2005-06-30

Last updated

2005-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Oral Cancer

Keywords

vascular endothelial growth factor-C, VEGF-CR, lymphangiogenesis, host inflammatory responses, oral carcinogenesis, oral cancers, oral premalignant lesions

Brief summary

The role of vascular endothelial growth factor-C (VEGF-C) and its receptors induced lymphangiogenesis and host inflammatory responses on the carcinogenesis of oral cancers and premalignant lesions

Detailed description

The role of vascular endothelial growth factor-C (VEGF-C) and its receptors induced lymphangiogenesis and host inflammatory responses on the carcinogenesis of oral cancers and premalignant lesions

Interventions

None listed

Study design

Observational model

DEFINED_POPULATION

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 85 Years

Healthy volunteers

Yes

Inclusion criteria

* oral cancer and oral precancer specimens

Exclusion criteria

* other diseases

Countries

Taiwan

Contacts

Primary ContactChun-Pin Chiang, DMSc

cpchiang@ha.mc.ntu.edu.tw886-2-23123456

Outcome results